ÂÜÀòÂÒÂ×

Terri Genthe is an accomplished regulatory affairs executive with extensive experience in the biopharmaceutical and food industries. Currently serving as SVP of Regulatory and Quality at Minervax ApS, Genthe previously held the position of Vice President of Regulatory Affairs at GeoVax Labs, Inc., leading discussions with FDA and EMA. Genthe's prior roles include Vice President of Regulatory Consulting/Solution Architecture at Genpact Pharmalink, where influential solutions for clients were developed, and Vice President of Global Regulatory Operations at Teva Pharmaceutical Industries Ltd., overseeing a global team managing diverse regulatory operations. With a significant tenure at Pfizer, including leading global regulatory strategy and submissions management, Genthe has also contributed to regulatory strategies at Centocor and MedImmune. Educational credentials include a Master’s in Biotechnology from The Johns Hopkins University, a Bachelor’s in Biology, cum laude, from William Paterson University, and an AAS in Medical Technology from County College of Morris.